132 related articles for article (PubMed ID: 36017826)
1. Oral Squamous Cell Carcinoma Following Acute Methotrexate Toxicity in a Psoriasis Patient: A Causal Association or Mere Co-Incidence.
Choudhary R; Singh A; Chhabra N; Gupta AK
Curr Drug Saf; 2023; 18(4):580-583. PubMed ID: 36017826
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate Use for Patients with Psoriasis and Risk of Cutaneous Squamous Cell Carcinoma: A Nested Case-control Study.
Giannopoulos F; Gillstedt M; Laskowski M; Bruun Kristensen K; Polesie S
Acta Derm Venereol; 2021 Jan; 101(1):adv00365. PubMed ID: 33320276
[TBL] [Abstract][Full Text] [Related]
3. Head and neck cancer. 3. Toxicity of 24-hour infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinomas.
Lefkowitz E; Papac RJ; Bertino JR
Cancer Chemother Rep; 1967 Sep; 51(5):305-11. PubMed ID: 4863189
[No Abstract] [Full Text] [Related]
4. Squamous cell carcinoma of the oral cavity in a woman with a 9-year history of ovarian cancer: is exposure to pegylated liposomal Doxorubicin a factor?
Randon G; Nicoletto MO; Milite N; Muggia F; Conte P
Oncologist; 2014 Apr; 19(4):429. PubMed ID: 24668330
[TBL] [Abstract][Full Text] [Related]
5. A Mechanistic Review of Methotrexate and Celecoxib as a Potential Metronomic Chemotherapy for Oral Squamous Cell Carcinoma.
Kamal MV; Rao M; Damerla RR; Pai A; Sharan K; Palod A; Shetty PS; Usman N; Kumar NAN
Cancer Invest; 2023 Feb; 41(2):144-154. PubMed ID: 36269850
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate in the treatment of squamous cell carcinomas of the head and neck.
Adler GF; Hagan B; Indyk JS; Reay-Young PS
Med J Aust; 1973 Apr; 1(15):747-8. PubMed ID: 4707371
[No Abstract] [Full Text] [Related]
7. Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy.
Machiels JP; Van Maanen A; Vandenbulcke JM; Filleul B; Seront E; Henry S; D'Hondt L; Lonchay C; Holbrechts S; Boegner P; Brohee D; Dequanter D; Louviaux I; Sautois B; Whenham N; Berchem G; Vanderschueren B; Fontaine C; Schmitz S; Gillain A; Schoonjans J; Rottey S
Oncologist; 2016 Dec; 21(12):1416-e17. PubMed ID: 27903924
[TBL] [Abstract][Full Text] [Related]
8. The treatment of squamous cell carcinoma of the head and neck with methotrexate and irradiation.
Friedman M; Daly JF
Am J Roentgenol Radium Ther Nucl Med; 1967 Feb; 99(2):289-301. PubMed ID: 6020797
[No Abstract] [Full Text] [Related]
9. Results in fifty cases of advanced squamous cell carcinoma of the head and neck treated by intravenous chemotherapy.
Priestman TJ
Br J Cancer; 1973 May; 27(5):400-5. PubMed ID: 4713171
[TBL] [Abstract][Full Text] [Related]
10. Treatment of carcinoma of the head and neck with intravenous methotrexate.
Leone LA; Albala MM; Rege VB
Cancer; 1968 May; 21(5):828-37. PubMed ID: 4172047
[No Abstract] [Full Text] [Related]
11. [Metastasizing squamous cell carcinoma in patients with psoriasis treated with immunosuppressive agents].
Jensen DB; Albrektsen SB; Krag C
Ugeskr Laeger; 1989 Jul; 151(29):1884-5. PubMed ID: 2773104
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
13. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW; Soulières D; Le Tourneau C; Dinis J; Licitra L; Ahn MJ; Soria A; Machiels JP; Mach N; Mehra R; Burtness B; Zhang P; Cheng J; Swaby RF; Harrington KJ;
Lancet; 2019 Jan; 393(10167):156-167. PubMed ID: 30509740
[TBL] [Abstract][Full Text] [Related]
14. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
15. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Machiels JP; Haddad RI; Fayette J; Licitra LF; Tahara M; Vermorken JB; Clement PM; Gauler T; Cupissol D; Grau JJ; Guigay J; Caponigro F; de Castro G; de Souza Viana L; Keilholz U; Del Campo JM; Cong XJ; Ehrnrooth E; Cohen EE;
Lancet Oncol; 2015 May; 16(5):583-94. PubMed ID: 25892145
[TBL] [Abstract][Full Text] [Related]
16. Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature.
Cao M; Shi E; Wang H; Mao L; Wu Q; Li X; Liang Y; Yang X; Wang Y; Li C
Int J Nanomedicine; 2022; 17():4293-4306. PubMed ID: 36134201
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma.
Kushwaha VS; Gupta S; Husain N; Khan H; Negi MP; Jamal N; Ghatak A
Cancer Biol Ther; 2015; 16(2):346-51. PubMed ID: 25756517
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between dental implants and oral squamous cell carcinoma.
Afrashtehfar KI; Almomani MM; Momani M
Evid Based Dent; 2022 Mar; 23(1):40-42. PubMed ID: 35338331
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".
Capizzi RL; DeConti RC; Marsh JC; Bertino JR
Cancer Res; 1970 Jun; 30(6):1782-8. PubMed ID: 4248129
[No Abstract] [Full Text] [Related]
20. Treatment of squamous cell carcinoma of the head and neck with combined methotrexate and irradiation.
Friedman M; DeNarvaes FN; Daly JF
Cancer; 1970 Sep; 26(3):711-21. PubMed ID: 5458276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
